A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults
Alice Minhinnick, Iman Satti, Stephanie Harris, Morven Wilkie, Sharon Sheehan, Lisa Stockdale, Zita-Rose Manjaly Thomas, Raquel Lopez-Ramon, Ian Poulton, Alison Lawrie, Samantha Vermaak, Alexandre Le Vert, Judith Del Campo, Fergal Hill, Paul Moss, Helen McShane
Research output: Contribution to journal › Article › peer-review
24Citations
(Scopus)
Fingerprint
Dive into the research topics of 'A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults'. Together they form a unique fingerprint.